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Abstract. 
 
Western blotting studies revealed that 
connexin43 (Cx43), one of the major gap junction pro-
teins in human vascular endothelial cells, is posttransla-
tionally modified during mitosis. This mitosis-specific 
modification results in a Cx43 species that migrates as a 
 
single protein band and was designated Cx43
 
m
 
. Cx43
 
m
 
 
was shown to be the result of additional Ser/Thr phos-
phorylation as indicated by: (
 
a
 
) the increased gel mobil-
ity induced by both alkaline phosphatase and the Ser/
Thr-specific protein phosphatase-2A (PP2A) and (
 
b
 
) 
the removal of virtually all 
 
32
 
P
 
i
 
 from Cx43
 
m
 
 by PP2A. 
Immunofluorescent confocal microscopy of mitotic 
cells revealed that Cx43 is intracellularly located, while 
in nonmitotic cells Cx43 is located at regions of cell–cell 
contact. Dye coupling studies revealed that mitotic en-
dothelial cells were uncoupled from each other and 
from nonmitotic cells. After cytokinesis, sister cells re-
sumed cell coupling independent of de novo protein 
synthesis. The mitosis-specific phosphorylation of Cx43 
correlates with the transient loss of gap junction inter-
cellular communication and redistribution of Cx43, sug-
gesting that a protein kinase that regulates gap junc-
tions is active in M-phase.
 
G
 
ap
 
 junctions are aqueous channels connecting adja-
cent cells through which small molecules with mo-
lecular weights of less than 1,000 can pass from
one cell to contacting cells (Loewenstein, 1981). These
channels are formed when oligomers of connexin proteins
in each of the apposing plasma membranes become aligned,
providing a continuous aqueous passageway between cells.
Gap junctions are ubiquitously distributed in normal ani-
mal cells and thus have been thought to be a principal
means of maintaining tissue homeostasis (Loewenstein,
1981). In addition to this function, these structures have
been implicated in the control of cell growth, notably by
their frequent absence or reduction in tumor or trans-
formed cells (Loewenstein, 1979; Trosko et al., 1990) and
by their corrective effects on cell proliferation when con-
nexins are transfected into these cells (Eghbali et al., 1991;
Mehta et al., 1991; Zhu et al., 1991; Rose et al., 1993). Reg-
ulation of gap junctions by growth and differentiation fac-
tors has also been extensively reported (Kamibayashi et al.,
1993; Meda et al., 1993; Trosko et al., 1993; Brissette et al.,
1994; Cronier et al., 1994; Hu and Xie, 1994; Zhang and
Thorgeirsson, 1994). In recent years, different connexins
have been cloned and found to form a family of proteins
with extensive homology (Beyer et al., 1990), and several
of these have been identified as candidate tumor suppres-
sor proteins (Eghbali et al., 1991; Lee et al., 1991; Mehta
et al., 1991; Zhu et al., 1991; Bond et al., 1994; Mesnil et al.,
1995; Hirschi et al., 1996).
The cell cycle is the basic unit of cell growth, and this
process necessarily involves extensive regulation and coor-
dination. Mitosis, in particular, is marked by dramatic mor-
phological and biochemical changes in both nuclear and
cytoplasmic elements. Several laboratories, including ours,
have reported on changes in gap junction–mediated inter-
cellular communication (GJIC)
 
1
 
 during the cell cycle using
various methods (Yee and Revel, 1978; Gordon et al.,
1982; Dermietzel et al., 1987; Su et al., 1990; Xie et al.,
1991; Stein et al., 1993). Furthermore, a number of studies
have shown a reduction in GJIC between mitotic and non-
mitotic cells (Goodall and Maro, 1986; Stein et al., 1992),
although contradictory results indicate that at least some
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Abbreviations used in this paper
 
: Cx43, connexin43; gap-FRAP, gap flu-
orescence redistribution after photobleaching (a dye coupling assay for
gap junctions); GJIC, gap junction intercellular communication; HUVEC,
human umbilical vein endothelial cells; PP2A, protein phosphatase-2A.
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form of gap junction activity might persist between mitotic
and nonmitotic cells (O’lague et al., 1970; Goodall and Maro,
1986). Although changes in the transcription and expres-
sion level of certain connexins during the cell cycle have
been demonstrated (Dermietzel et al., 1987; Lee et al., 1992),
no cell cycle–dependent posttranslational modification of
connexin(s) has yet been identified.
In this paper, we report on and characterize a mitosis-
specific modification of one of the gap junction proteins
(connexin43 [Cx43]) in vascular endothelial cells that had
been suggested in an earlier study on cell cycle–dependent
GJIC (Xie and Hu, 1994
 
a
 
). This mitosis-specific species of
Cx43 was often localized to intracellular compartments in
mitotic cells. Using a dye-transfer technique, we observed
reduced coupling between mitotic cells and nonmitotic cells
followed by recoupling of sister cells after cytokinesis.
 
Materials and Methods
 
Cell Culture and Mitotic Selection
 
Human umbilical vein endothelial cells (HUVEC), strain HX1, was iso-
lated from a fresh human umbilical cord according to established proce-
dures (Jaffe et al., 1973). HUVEC strain H101 was a generous gift from
Dr. Thomas Maciag (American Red Cross, Rockville, MD). Human arte-
rial endothelial cells were the kind gift of Dr. Boon Ooi (Veteran’s Ad-
ministration Medical Center, Washington, DC). All endothelial cells were
cultured according to standard methods (Maier et al., 1990). Rat vascular
smooth muscle cells were kindly provided by Dr. William Weglicki (Divi-
sion of Experimental Medicine, The George Washington University Med-
ical Center, Washington, DC). These cells were cultured in DME supple-
mented with 10% FBS.
Mitotic cells were obtained by collecting nocodazole- or colcemid-
treated cells. A mitotic inhibitor, nocodazole at 0.4 
 
m
 
g/ml (Sigma Chemi-
cal Co., St. Louis, MO) or colcemid at 0.1 
 
m
 
g/ml (GIBCO BRL, Gaithers-
burg, MD), was added to cell culture 3 h after removal from a double
thymidine block, which arrests cells at the G1/S boundary (Adams, 1990).
5 h later, floating and loosely attached mitotic cells were collected by gen-
tle aspiration. Occasionally, mitotic cells were obtained after treating HU-
VEC with 0.5 
 
m
 
g/ml nocodazole overnight without a prior thymidine
block. Mitotic cells obtained by either procedure yielded the same results.
By trypan blue staining, it was determined that the collected mitotic cells
had a viability of 85–99%. When reseeded, 
 
.
 
80% of the mitotic cells could
adhere to culture dishes. Cells still adhering to the substratum after mi-
totic shakeoff or, alternatively, unsynchronized cells were dislodged with
brief treatment of trypsin-EDTA and used as controls in all Cx43 analyses.
 
Gap Fluorescence Redistribution after Photobleaching
 
Cell coupling assays were performed as previously described (Xie and Hu,
1994
 
b
 
) using gap fluorescence redistribution after photobleaching (gap-
FRAP) techniques developed by Wade et al. (1986). Briefly, cells were
stained at room temperature with 7.3 
 
m
 
g/ml carboxyfluorescein diacetate
for 15 min. Using an interactive laser cytometer (model ACAS 570; Me-
ridian Instruments, Okemos, MI), selected cells were bleached with 8–14
50-ms pulses of a strong 488-nm laser beam. The bleached cells included
rounded-up or dividing mitotic cells remaining in physical contact with
nonmitotic cells after vigorously shaking the culture dish (Table I) or one
of a pair of sister cells right after cytokinesis (see Fig. 4). Positive controls
consisted of bleached nonmitotic cells that were attached to other nonmi-
totic cells, while negative controls were bleached cells that were not in
contact with any other cells. The fluorescence in unbleached cells was also
monitored over time and used to correct for background leakage or
bleaching of dye during the course of the experiment. The time-depen-
dent recovery of fluorescence after photobleaching was monitored for
each cell by repeated laser scannings during the first 3 min after bleaching.
Recovery rates represent the percentage of dye recovery/min relative to
the initial (prebleach) fluorescence for the respective cells, as determined
by the Cell–Cell Communication software provided by Meridian Instru-
ments.
 
Alkaline Phosphatase Digestion and Western Blots
 
Control and mitotic lysates were collected from human arterial endothelial
cells as described earlier. Mitotic cell lysate buffer was exchanged for alka-
line phosphatase digestion buffer (100 mM Tris, pH 8.0, 40 mM NaCl, 1 mM
MgCl
 
2
 
, and 0.1% SDS) by repeated centrifugation in a concentrator
(model Centricon-30; Amicon, Danvers, MA). Briefly, lysis buffer was ex-
changed for digestion buffer by adding 1 ml of digestion buffer (3
 
3
 
) and
concentrating the sample to 
 
z
 
0.2 ml by centrifugation (model J2-21;
Beckman Instruments, Fullerton, CA) at 5,000 rpm for 
 
z
 
40 min. Samples
were digested with 30 U of alkaline phosphatase (BMB, Molecular Biology
grade; 20 U/
 
m
 
l) for 20 h at 4
 
8
 
C in the presence or absence of 2.5 mM
NaVO
 
4
 
 and 50 mM NaF. Finally, all samples were treated with gel cocktail
buffer, boiled for 5 min, and resolved on a 10% SDS-polyacrylamide gel
with an acrylamide/bis-acrylamide ratio of 30:0.8. Proteins were trans-
ferred to nitrocellulose and immunoblotted for Cx43 as described in Laird
et al. (1995).
In other experiments, Western blotting for the detection of Cx43 was
performed as previously described (Xie and Hu, 1994
 
a
 
,
 
b
 
). In essence, mi-
totic or control cells were lysed directly in the SDS gel-loading buffer. The
lysates were boiled, sonicated, and centrifuged. 50 
 
m
 
g of protein from each
sample was fractionated by 10% SDS-PAGE and transferred to nitrocel-
lulose membranes. The membranes were sequentially incubated with mouse
monoclonal anti-Cx43 antibody (Zymed Labs, S. San Francisco, CA), rab-
bit anti–mouse IgG antibody (Fisher Scientific, Pittsburgh, PA), and HRP-
conjugated goat anti–rabbit IgG antiserum (Zymed Labs) before detec-
tion of the HRP-labeled bands with an enhanced chemiluminescence kit
(Amersham Corp., Arlington Heights, IL). In some experiments, CT-360,
a rabbit polyclonal antiserum against the carboxy terminus of Cx43 (Laird
and Revel, 1990), was used in place of the anti-Cx43 mouse monoclonal
antibody and secondary rabbit anti–mouse IgG antiserum.
 
Immunoprecipitation of Cx43
 
For some experiments, Cx43 (either unlabeled or labeled with 
 
32
 
P
 
i
 
) was
immunoprecipitated with CT-360. In these cases, equal amounts of the di-
alyzed solubilized protein from the different samples were incubated with
the antiserum followed by immunoprecipitation with immobilized protein
A (Pierce, Rockford, IL). After thorough washing of the protein A com-
plexes with washing buffer I (50 mM Tris, 150 mM NaCl, 0.1 mM EDTA,
and 0.5% Tween-20, pH 7.5), followed by washing with buffer II (100 mM
Tris, 200 mM NaCl, 2 M urea, and 0.5% Tween-20, pH 7.5), and finally
water, samples were mixed with 2
 
3
 
 SDS gel-loading buffer and analyzed
by SDS-PAGE followed by Western blotting or autoradiography.
 
Metabolic Labeling and Treatment with Protein 
Phosphatase-2A, a Protein (Ser/Thr) Phosphatase
 
Mitotic HUVEC were collected and labeled with [
 
32
 
P]orthophosphate
(ICN Biomedicals, Costa Mesa, CA) at 1 mCi/ml for 2 h in phosphate-
deficient DME containing 10% dialyzed FBS (dialyzed against 0.15 NaCl
overnight) in the presence of 0.4 
 
m
 
g/ml nocodazole. The cells were then
lysed, dialyzed, and immunoprecipitated as described above. After wash-
ing with washing buffer I, the protein A complexes were washed twice
with protein phosphatase-2A (PP2A) dilution buffer containing 20 mM
Hepes, 1 mM DTT, 100 
 
m
 
g/ml BSA, 50 
 
m
 
M leupeptin, 1 mM MnCl
 
2
 
 (Scheidt-
mann et al., 1991). The immunoprecipitates were then mixed with either
0.3 U PP2A (Upstate Biotechnology Inc., Lake Placid, NY) or dilution
buffer alone. The mixtures (50 
 
m
 
l) were incubated at 30
 
8
 
C for 1 h. The
phosphatase reaction was terminated by addition of SDS gel-loading buffer.
Samples were then analyzed by SDS-PAGE and autoradiography. Simi-
larly, immunoprecipitated Cx43 from unlabeled mitotic cells was treated
with PP2A 
 
1
 
 or 
 
2
 
 phosphatase inhibitors (2 mM vanadate [Sigma Chemical
Co.] and 1 
 
m
 
M okadaic acid [Calbiochem]) and analyzed by Western blotting.
 
Immunofluorescence Studies
 
Mitotic cells were obtained as previously described. The harvested cells
were then fixed in 100% ice-cold ethanol for 30 min before rehydration
with PBS. The anchored nonmitotic cells remaining on glass coverslips in
the dish after the mitotic shakeoff were also fixed with ethanol and rehy-
drated. Mitotic cells were attached to Cell-Tak–coated glass coverslips by
centrifuging at 1,500 
 
g
 
 for 5 min. Both mitotic and nonmitotic cells were
immunolabeled with the mouse monoclonal anti-Cx43 antibody or an an-
tiserum (CT-360) generated against the carboxy terminus of Cx43 (Laird 
Xie et al. 
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and Revel, 1990). Both immunological reagents produced similar results,
and only results obtained with the commercial anti-Cx43 antibody are
shown in this report. Antibody binding to Cx43 was detected by incubat-
ing the cells in goat anti–mouse antibody conjugated to rhodamine.
 Immunolabeled cells were analyzed on a confocal microscope (model 410
LSM; Carl Zeiss, Inc., Thornwood, NY). In the case of mitotic cells, the cell
thickness in the Z dimension was determined and a confocal optical slice
(
 
z
 
1 
 
m
 
m thick) for Cx43 was taken at or near the center of the cell. Noncon-
focal transmitted light images of the mitotic cells were taken at the same Z
settings. In some cases, three to five confocal optical slices of Cx43 label-
ing were combined to more accurately illustrate the spatial localization of
a broader representation of Cx43 in mitotic cells. Finally, single optical
images of Cx43 in nonmitotic cells were collected. All images were printed
on a high resolution printer (model 8300; Kodak, Inc., Rochester, NY).
 
Results
 
Cx43 Protein Is Modified during Mitosis
 
Western blot analyses with a monoclonal antibody against
Cx43 revealed a higher relative molecular mass isoform of
Cx43 in mitotic cells (Fig. 1, lanes 
 
2
 
, 
 
4
 
, 
 
5
 
, 
 
6
 
, and 
 
8
 
). This
unique species, designated Cx43
 
m
 
, was estimated at 47–48
 
M
 
r
 
 and was not restricted to a single cell type inasmuch as
two strains of HUVEC (strains HX1 and H101; Fig. 1,
lanes 
 
5
 
 and 
 
6
 
, respectively) as well as rat vascular smooth
muscle cells (Fig. 1, lanes 
 
7
 
 and 
 
8
 
) exhibited this mitosis-
specific modification. As shown in Fig. 1, mitotic cells con-
tained predominantly one Cx43 species of higher relative
molecular mass, while control cells contained up to three
species of lower relative molecular mass. This mobility
shift is unlikely to be the direct result of treatment with a
specific mitotic inhibitor in that both colcemid (lane 
 
2
 
) and
nocodazole (lane 
 
4
 
) arrest gave rise to Cx43 bands of similar
mobility, and unsynchronized control cells that were
treated for a few hours with nocodazole contained only
the faster mobility forms of Cx43 (data not shown). More-
over, the mobility shift of Cx43 observed in mitotic cells is
unrelated to a general rounding-up effect per se since the
control cells were detached from the substratum with
trypsin (causing the cells to round-up) before being lysed
with the SDS gel-loading buffer.
 
Cx43 Is Additionally Phosphorylated during Mitosis
 
As shown in Fig. 2 (lane 
 
M
 
 
 
1
 
 
 
AP
 
), alkaline phosphatase
treatment eliminated the gel shift of Cx43 seen in mitotic
cells (lane 
 
M
 
), suggesting that the mitosis-specific modifi-
cation of Cx43 is a phosphorylation phenomenon. Further-
more, the phosphatase-mediated conversion of Cx43
 
m
 
 to a
Cx43 species of lower relative molecular mass was inhib-
ited by phosphatase inhibitors (lane 
 
M
 
 
 
1
 
 
 
AP
 
 
 
1
 
 
 
I
 
). Nonmi-
totic cells (lane 
 
A
 
) had the well-characterized pattern of
Cx43 species at relative molecular masses lower than Cx43
 
m
 
.
 
Mitosis-specific Phosphorylation of Cx43 Is on Ser/Thr
 
Serine phosphorylation has been shown to correlate with
gap junction assembly (Musil et al., 1990; Musil and Good-
enough, 1991) as well as with 12-
 
O
 
-tetradecanoylphorbol-
13-acetate and EGF stimulation (Brissette et al., 1991; Lau
et al., 1992; Warn-Cramer et al., 1996). In addition to serine
phosphorylation, Cx43 can be modified on tyrosine resi-
due(s) by 
 
src
 
, which has been shown to inhibit GJIC
(Crow et al., 1990; Filson et al., 1990; Swenson et al., 1990).
Because 
 
src
 
 can be activated by a key initiator of mitosis,
M-phase–promoting factor (Morgan et al., 1989; Shenoy
et al., 1989), the possibility of Cx43 being phosphorylated
by 
 
src
 
 on tyrosine residue(s) during mitosis was investi-
gated by Western analyses of immunoprecipitated, unla-
beled Cx43 protein with an anti–tyrosine phosphate anti-
serum. Although both mitotic and nonmitotic Cx43 were
precipitated by the polyclonal anti-Cx43 antiserum CT-
360, neither form of Cx43 reacted with the polyclonal anti–
tyrosine phosphate antiserum on Western blots (data not
shown). Absence of phosphotyrosine was further corrobo-
rated by the observation that the Ser/Thr-specific protein
phosphatase PP2A, like alkaline phosphatase, was able to
shift the Cx43
 
m
 
 species (Fig. 3 
 
A
 
, lane 
 
2
 
) to the species of
lowest relative molecular mass (highest mobility) (Fig. 3
 
A
 
, lane 
 
1
 
) as well as remove virtually all 
 
32
 
P-labeled phos-
phate from immunoprecipitated Cx43
 
m
 
 (Fig. 3 
 
B
 
, lane 
 
2
 
).
In comparison to Cx43 from nonmitotic cells, both immu-
noprecipitated and in whole cell lysate (Fig. 3 
 
A
 
, lanes 
 
3
 
and 
 
4
 
, respectively), the Cx43
 
m
 
 species (both immunopre-
cipitated and in whole cell lysate) appears to have a
slightly higher relative molecular mass (Fig. 3 
 
A
 
, lanes 
 
2
 
and 
 
5
 
, respectively), consistent with Cx43 banding patterns
seen in Fig. 1. Furthermore, phosphoamino acid analysis
by thin layer electrophoresis of 
 
32
 
P-labeled mitotic Cx43
hydrolyzed by treatment with HCl revealed the presence
Figure 1. Western blot analyses revealed that Cx43 in mitotic cells
from HUVEC strains HX1 and H101 and rat vascular smooth
muscle cells had slower mobility, with a relative molecular mass
of 47–48. Lanes 1 and 2, control nonmitotic and colcemid-arrested
mitotic HX1 cells, respectively; lanes 3 and 4, control nonmitotic
and nocodazole-arrested mitotic HX1 cells, respectively; lanes 5
and 6, mitotic HX1 and H101 HUVEC cells, respectively; lanes 7
and 8, nonmitotic and mitotic rat vascular smooth muscle cells,
respectively.
Figure 2. The mitotic form of
Cx43 is alkaline phosphatase
sensitive. Control human arte-
rial endothelial cell lysates (A)
or mitotic cell lysates (M) were
treated with alkaline phos-
phatase (AP) in the presence
or absence of inhibitors (I).
Samples were resolved by
SDS-PAGE and immunoblot-
ted for Cx43. Note that the mi-
totic form of Cx43 (Cx43m) was
specifically sensitive to alkaline
phosphatase. 
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of only phosphoserine (data not shown). Taken together,
these data suggest that the phosphorylated form of Cx43
unique to mitotic cells arises most likely by phosphoryla-
tion of a serine residue(s), although limits in the sensitivity
of the techniques used might not have detected minor
phosphorylation of tyrosine or threonine. However, addi-
tional serine phosphorylation has also been observed in
mitotic Rat-1 fibroblasts, either transformed with v-
 
src
 
 or
overexpressing c-
 
src
 
, (Lau, A., personal communication).
 
Mitotic Cells Are Transiently Uncoupled from 
Nonmitotic Cells
 
The coupling of mitotic HUVEC with nonmitotic cells was
assessed through gap-FRAP studies that involved moni-
toring the flow of fluorescent dye from one cell into an at-
tached photobleached cell. Gap-FRAP was conducted on
rounded-up mitotic cells or dividing cells (doublets) that re-
mained attached to neighboring or underlying nonmitotic
cells after culture dishes had been vigorously shaken. Ta-
ble I summarizes the fluorescence recovery data obtained
for mitotic and control cells. The data show that the mean
recovery rate for bleached mitotic cells in contact with non-
mitotic cells is substantially lower than that of bleached
nonmitotic cells and is similar to the mean recovery rate of
bleached isolated cells that lacked any neighboring cell
contacts (negative controls).
Colcemid-arrested mitotic HUVEC underwent cytoki-
nesis within 2 h after resuspension in warm culture me-
dium and attachment to the substratum. Microscopic ob-
servation suggested that the process of cytokinesis started
immediately after attachment. Gap-FRAP analyses con-
ducted on these newly divided cells show that the siblings
resumed GJIC shortly after cytokinesis (Fig. 4 A). The
characteristic kinetics of dye recovery (shown by the lower
curve in Fig. 4 A) coupled with the observed suppression
of dye recovery by 0.1% octanol, a gap junction inhibitor
(Fig. 4 B), argue against the involvement of remaining cy-
toplasmic bridges between sister cells. On the other hand,
recovery of GJIC could not be blocked when the mitotic
cells were replated in the presence of cycloheximide (100
mg/ml) (Fig. 4 C), suggesting that de novo protein synthe-
sis is not necessary for the reestablishment of functional
gap junctions.
Redistribution of Cx43 Protein during Mitosis
To determine the distribution pattern of Cx43 during mi-
tosis, mitotic cells were immunolabeled for Cx43 and ana-
lyzed on a confocal microscope. The transmitted light im-
ages (Fig. 5, A and C) of mitotic cells in comparison with
the corresponding confocal immunofluorescent images
(Fig. 5, B and D) show that Cx43 was often localized to in-
tracellular compartments when optical sections were taken
through the center of the cell. Moreover, optical slice re-
constructions revealed a substantial amount of redistrib-
uted Cx43 in mitotic cells (Fig. 5 E, arrows) as well as an
overall increase in intracellular cytoplasmic staining. Con-
versely, nonmitotic cells that remained on the substrate af-
ter mitotic shake-off showed the typical distribution of
Cx43, principally at locations of cell–cell contact (Fig. 5 F).
Discussion
In this study we have identified and characterized a mito-
sis-specific species of Cx43 (Cx43m) in mitotic vascular en-
dothelial and smooth muscle cells. Cx43m runs at a higher
relative molecular mass on SDS-PAGE gels than at least
two other well-characterized species of Cx43 that corre-
spond to the unphosphorylated form of Cx43 and the
Cx43(P1) species (Musil et al., 1990; Laird et al., 1991).
However, the Cx43m species of Cx43 has only a slightly
higher relative molecular mass than Cx43(P2) (Musil et al.,
1990) and is similar in relative molecular mass to an EGF-
induced Cx43 species (Lau et al., 1992). It is doubtful that
Cx43m is directly related to the EGF-induced species of Cx43
or to any other reported phosphorylated species of Cx43
that are inducible by 12-O-tetradecanoylphorbol-13-ace-
tate (Oh et al., 1991; Berthoud et al., 1992; Moreno et al.,
1994), but this remains to be seen.
Figure 3. Western blot (A) and autoradiogram (B) of immuno-
precipitated Cx43m after PP2A digestion. (A) Cx43 was immuno-
precipitated from human arterial endothelial cells using polyclonal
rabbit anti-Cx43 antiserum (CT-360). The immunoprecipitates
from mitotic cells were treated for 1 h at 308C with PP2A (0.25
U/ml), in the absence (lane 1) or presence (lane 2) of phosphatase
inhibitors, and analyzed by Western blotting. A nonmitotic sam-
ple was also immunoprecipitated for comparison (lane 3). Also
shown on the Western blot are whole cell lysates from nonmitotic
(lane 4) and mitotic (lane 5) cells. The broad band above the
Cx43 protein is the immunoprecipitating rabbit antibody that is
recognized by the HRP-conjugated goat anti–rabbit IgG antise-
rum. (B) Mitotic HUVEC cells were labeled with [32P]orthophos-
phate for 2 h before immunoprecipitation. The immunoprecipi-
tates were treated either with PP2A or with dilution buffer only,
under conditions similar to those described above. Samples were
analyzed by SDS-PAGE and autoradiography. Lane 1, sample
treated with dilution buffer only; lane 2, sample treated with
PP2A, which removes virtually all of the 32P label from the immu-
noprecipitated Cx43m.
Table I. Comparison of Recovery Rates for Photobleached 
Mitotic and Nonmitotic Cells
Cell
Recovery rate*
(Percentage of initial F/min) SEM
Nonmitotic 6.251 (7)‡ 0.882
Mitotic 0.766 (7) 0.254
Isolated 0.452 (5) 0.139
*Corrected for background leakage or bleaching.
‡Numbers in parentheses correspond to number of cells analyzed.Xie et al. Mitosis-specific Modification of Cx43 207
Although the kinase responsible for the mitosis-specific
phosphorylation of Cx43 on serine is unknown, a consen-
sus site for phosphorylation by p34cdc2 (the kinase compo-
nent of M-phase–promoting factor) has been identified on
Cx43 (Kanemitsu and Lau, 1993). The generation of Cx43m
cannot be attributed to the process of rounding up and lift-
ing off from the substratum since trypsinized nonmitotic
cells do not contain this form of the Cx43 protein. Further-
more, this high relative molecular mass species could not
be induced by the short term addition of mitotic inhibitors
to nonmitotic cells, thus ruling out a simple drug effect.
While we cannot eliminate the possibility that Cx43m is solely
a product of cells in metaphase arrest, the presence of this
predominant species of Cx43 in M-phase cells suggests
that alterations in gap junction activity/assembly/distribu-
tion might be specifically coordinated with the process of
cell division and growth.
Gap-FRAP analyses of GJIC between mitotic and non-
mitotic cells revealed the absence of coupling between
these cells. This result is similar to that of some previously
published studies (Goodall and Maro, 1986; Stein et al.,
1992, 1993). The lack of dye coupling correlates with the
phosphorylation of Cx43 protein during mitosis, suggest-
ing that at least one consequence of the mitosis-specific
modification might be the closure or disassembly of gap
junctions between mitotic and nonmitotic cells, although
the cellular mechanism of this downregulation is not known.
Also unknown is the extent to which cell-to-cell transfer of
material is inhibited, as electrical coupling has been shown
to persist between mitotic and nonmitotic cells (O’lague
et al., 1970; Goodall and Maro, 1986), even in the absence
of dye coupling.
Gap-FRAP analyses of sister cells after cytokinesis indi-
cate that cell coupling can resume in the absence of de
novo protein synthesis. This result suggests several possi-
ble interpretations: (a) Cx43m, which is the predominant
Cx43 species in mitotic cells, can be recycled into func-
tional gap junctions; (b) a previously synthesized minor
portion of nonmitotic Cx43 (residing in the endoplasmic
reticulum or Golgi apparatus) is incorporated into the
plasma membrane and new gap junctions are assembled;
or (c) other endothelial connexins are responsible for cell
coupling after division. To date, no clear evidence has been
presented that demonstrates that connexins can recycle.
On the other hand, intracellular reservoirs of Cx43 are
well documented, as Cx43 has been localized to the Golgi
apparatus of cardiomyocytes (Laird et al., 1993) and mam-
mary tumor cells (Laird et al., 1995). Furthermore, in mam-
mary tumor cells, the ER/Golgi store of Cx43 can be used
to assemble gap junctions in the absence of protein synthe-
sis (Laird et al., 1995). In other studies, Moskalewski et al.
Figure 4. A representative set of gap-FRAP experiments exam-
ining the resumption of GJIC after cytokinesis. One of a pair of
sister cells (HX1) was photobleached in each experiment. Cells
were scanned at 0.8-min intervals after bleaching. Pseudocolor
fluorescence images of the cells are shown at three time points:
before bleaching, immediately after bleaching, and at z3 min af-
ter bleaching. The lower curves in the % prebleach fluorescence
vs. time graphs depict the time-dependent fluorescence changes
in the respective photobleached cells. In coupled cell pairs, a de-
crease in fluorescence in the unbleached cell is also observed (a
and c, upper curves) as expected, as dye is transferred to the pho-
tobleached cell. (A) Gap-FRAP on a pair of sister cells shows
that the siblings resumed GJIC after cytokinesis (n 5 10). (B)
Octanol inhibited the gap junction–mediated dye transfer be-
tween sister cells after cytokinesis. Octanol (0.1%) was added im-
mediately before gap-FRAP analyses (n 5 5). (C) Gap-FRAP on
a pair of sister cells shows that the resumption of gap junctions
between sister cells could not be blocked by cycloheximide treat-
ment. Mitotic cells were reseeded in culture dishes for 3 h in the
presence of 100 mg/ml cycloheximide (n 5 5).The Journal of Cell Biology, Volume 137, 1997 208
(1994) showed that Cx43 gap junctions could assemble af-
ter cytokinesis even if protein trafficking was blocked with
brefeldin A, suggesting that Cx43 in compartments that
are more distal to the trans-Golgi was being used for gap
junction assembly. The possibility that other connexin
molecules (e.g., Cx40, Beyer et al., 1992; or Cx37, Reed et al.,
1993) take part in cell coupling immediately after cytoki-
nesis cannot be excluded, and it will be interesting to see if
any of these connexins undergo a similar mitosis-specific
modification.
Immunofluorescence analyses indicate that Cx43 is in-
deed redistributed in mitotic cells and appears to be con-
centrated in intracellular structures. While some Cx43 is
located near the plasma membrane, it is not clear if this
protein still resides on the cell surface or if it is in the early
stages of internalization. This apparent internalization of
Figure 5. Spatial distribution of Cx43 in mitotic and nonmitotic HX1 cells. Transmitted light images (A and C) of mitotic cells immuno-
labeled for Cx43 (B and D) show the spatial distribution of Cx43. Note the punctate labeling of Cx43 in intracellular compartments (ar-
rows). (E) Reconstructed image of Cx43 in mitotic HX1 cells. Mitotic cells immunolabeled for Cx43 were optically sectioned and three
images collected at 1-mm intervals were superimposed to illustrate a succession of Cx43-positive cellular locations (arrows). The mitotic
cell in the insert is a reconstruction of five images collected at 1-mm intervals. (F) A confocal microscopic image for Cx43 in nonmitotic
HX1 cells revealed punctate labeling at sites of cell–cell apposition with little intracellular labeling. Bars, 10 mm.Xie et al. Mitosis-specific Modification of Cx43 209
junctional protein is one possible mechanism by which cell
coupling between mitotic cells and nonmitotic cells could
be reduced, although changes in gating, or alternate mech-
anisms, cannot be excluded. In contrast, Cx43 in anchored
nonmitotic cells is observed at the contact regions between
cells with limited localization in cytoplasmic compartments.
Thus, the mitosis-specific phosphorylation of Cx43 may
signal processes that lead to internalization and eventual
degradation of Cx43 and/or closure of gap junction chan-
nels between mitotic and nonmitotic cells.
In summary, the identification of a mitosis-specific phos-
phorylation of Cx43 is the first demonstration of a cell cy-
cle–related change in the posttranslational modification of
a connexin protein. This phase-dependent modification is
associated with the downregulation of GJIC between mi-
totic and nonmitotic cells as well as with a redistribution of
Cx43 in mitotic cells. This relationship further emphasizes
the coordination of molecular and cellular events that ac-
company mitosis.
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